Inlyta, also known as Axitinib tablets, is a medication used to treat advanced kidney cancer (renal cell carcinoma). It contains Axitinib as the active ingredient and is manufactured by Pfizer Pharmaceuticals, Inc. Each pack of Inlyta contains 28 tablets of 1 mg strength.
Uses:
Inlyta is used to treat advanced kidney cancer that has spread to other parts of the body. It is commonly prescribed after other cancer treatments have failed to work effectively.
Usage and Dosage:
Inlyta should be taken orally by swallowing the tablet with a glass of water. The recommended dosage for Inlyta is 5 mg taken twice daily, with 12 hours between doses. The dosage may be adjusted depending on the patient’s response and tolerance.
Storage Conditions:
Inlyta should be stored at room temperature, away from moisture and direct sunlight. The medication should be kept in its original container with the lid tightly closed.
Mechanism of Action:
Axitinib works by inhibiting the growth of blood vessels that supply oxygen and nutrients to cancer cells. This slows down the growth and spread of cancer cells, essentially starving them of the nutrients they need to thrive and multiply.
Contraindications:
Inlyta is contraindicated in patients with a history of allergic reactions to Axitinib or any of its components. It is also not recommended for use in patients with severe liver disease.
Interactions:
Inlyta may interact with other medications, including blood thinners, antibiotics, antifungal medications, and other cancer drugs. It is important to inform the healthcare provider about any medications the patient is taking before starting Inlyta.
Side Effects:
The most common side effects of Inlyta include high blood pressure, fatigue, decreased appetite, nausea, vomiting, and diarrhea. Other side effects may include liver problems, bleeding, and thyroid gland problems. If any side effects occur, the patient should speak with their doctor for advice.
Inlyta should only be used under the supervision of a healthcare professional and with a valid prescription. If you have any questions or concerns about Inlyta, talk to your healthcare provider.
Reviews
There are no reviews yet.